S 2720 · 117th Congress · Armed Forces and National Security

Veterans’ Prostate Cancer Treatment and Research Act

Introduced 2021-09-13· Sponsored by Sen. Moran, Jerry [R-KS]· Senate

Bill Progress

Introduced
2
Committee
3
Senate Vote
4
House
5
Enacted
Latest: Committee on Veterans' Affairs. Ordered to be reported without amendment favorably.(2021-12-15)

Plain Language Summary

[AI summary unavailable — showing source text] Veterans' Prostate Cancer Treatment and Research Act This bill requires the Department of Veterans Affairs (VA) to establish in its National Surgery Office an interdisciplinary clinical pathway for all stages of prostate cancer. Clinical pathways are health care management tools designed around research and evidence-based practices that provide direction for the care and treatment of a specific condition. The clinical pathway must include specified elements, such as a diagnosis pathway and a treatment pathway. The VA must consult with and incorporate feedback from (1) veterans who have received prostate cancer care at its medical facilities, and (2) experts in multidisciplinary cancer care and clinical research. Additionally, the VA must publish the clinical pathway on a public VA website and annually update the pathway as needed based on medical literature and evidence-based guidelines. The bill also requires the VA to submit a plan to establish a prostate cancer program using the comprehensive prostate cancer clinical pathway.…

Summarized by Claude AI · Non-partisan · For informational purposes only

CBO Cost Estimate

Congressional Budget Office

S. 2720, Veterans’ Prostate Cancer Treatment and Research Act

Feb 4, 2022

As ordered reported by the Senate Committee on Veterans’ Affairs on December 15, 2021

Full CBO report ↗

Official non-partisan budget analysis by the Congressional Budget Office

Cosponsors (6)

4 Democrats2 Republicans